Skip to search formSkip to main contentSkip to account menu

BRL-26921

Known as: BRL 26921, BRL26921 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Anistreplase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
[Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct].
The thrombolytic properties of anisoylated plasminogen streptokinase activator complex (BRL 26921) and clinical results of the… 
1985
1985
Efficacy of BRL 26921, a new fibrinolytic agent for intravenous infusion, in acute myocardial infarction
The main goal of therapeutic thrombolysis in acute myocardial infarction is early reperfusion of acutely obstructed coronary… 
1985
1985
BRL 26921, A new thrombolytic agent for pulmonary embolism
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)